Article

Ability to Regulate Emotion Is Predicted by Depressive Symptoms and Cognitive Function in a Cardiac Sample.

Mary Beth Spitznagel, PhD Assistant Professor, Department of Psychology, Kent State University, and Summa Health System, Center for Cardiopulmonary Research, Akron, Ohio. Vanessa Potter, BA Research Coordinator, Summa Health System, Center for Cardiopulmonary Research, Akron, Ohio. Lindsay A. Miller, BS Research Assistant, Department of Psychology, Kent State University, Ohio, and Summa Health System, Center for Cardiopulmonary Research, Akron, Ohio. Angela N. Roberts Miller, MS, MPH Research Assistant, Department of Psychology, Kent State University, Ohio, and Summa Health System, Center for Cardiopulmonary Research, Akron, Ohio. Joel Hughes, PhD Associate Professor, Department of Psychology, Kent State University, Ohio, and Summa Health System, Center for Cardiopulmonary Research, Akron, Ohio. Jim Rosneck, RN Director, Center for Cardiovascular Research, Summa Health System, Akron, Ohio. John Gunstad, PhD Associate Professor, Department of Psychology, Kent State University, Ohio, and Center for Cardiopulmonary Research, Summa Health System, Akron, Ohio.
The Journal of cardiovascular nursing (Impact Factor: 1.47). 06/2012; DOI: 10.1097/JCN.0b013e318256be99
Source: PubMed

ABSTRACT BACKGROUND:: Reduced ability to regulate emotion is exhibited in depressed individuals as well as patients with neurocognitive change. Given that patients with cardiovascular disease (CVD) often exhibit both cognitive and mood changes, these could, in combination, lead to increased volatility of emotion. OBJECTIVE:: The current study examined the association between ability to regulate emotion, depressive symptoms, and cognitive function in a sample of patients with CVD. METHODS:: Ninety-one CVD patients referred for outpatient stress testing completed brief cognitive testing and self-report measures of emotion regulation and depressive symptoms. RESULTS:: Hierarchical multiple regression analyses revealed that depressive symptoms (P < .001) and executive function (P < .05) independently contribute to emotion regulation. The interaction between these variables demonstrates that elevated depressive symptoms and decreased executive function predict increased emotion dysregulation. CONCLUSION:: Findings suggest that in combination, elevated depressive symptoms and executive dysfunction contribute to poorer ability to regulate emotion in patients with CVD. Given the prevalence of depression and cognitive change in this population, these findings underscore the importance of clinician awareness of these issues in this population and suggest clinical implications for treatment of mental health issues, especially emotion regulation, in this population.

0 Bookmarks
 · 
114 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Mini-Mental State (MMS) examination is a widely used screening test for dementia. The Modified Mini-Mental State (3MS) incorporates four added test items, more graded scoring, and some other minor changes. These modifications are designed to sample a broader variety of cognitive functions, cover a wider range of difficulty levels, and enhance the reliability and the validity of the scores. The 3MS retains the brevity, ease of administration, and objective scoring of the MMS but broadens the range of scores from 0-30 to 0-100. Greater sensitivities of the 3MS over the MMS are demonstrated with the pentagon item drawn by 249 patients. A summary form for administration and scoring that can generate both the MMS and the 3MS scores is provided so that the examiner can maintain continuity with existing data and can obtain a more informative assessment.
    The Journal of Clinical Psychiatry 09/1987; 48(8):314-8. · 5.81 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The objectives of this study were to examine the prevalence of depression in hospitalized, medically ill, older patients with and without congestive heart failure (CHF), and examine correlates, course, predictors of outcome, and treatment of depression in patients with CHF. A consecutive sample of 542 patients age 60 or over admitted to inpatient services of Duke University Medical Center were systematically screened by a psychiatrist for depression using the Diagnostic Interview Schedule; 342 depressed cases and nondepressed controls were identified. Of these, 107 had a primary or secondary diagnosis of CHF. Among patients with CHF, major depression was identified in 36.5%, a rate that was significantly higher than for patients without CHF (25.5%); the difference was largely explained by low rates of major depression in cardiac patients without CHF (17.0%) who had less severe physical illness. Minor depression was also present in 21.5% of CHF patients, but was not more prevalent than in patients without CHF (17.0%). Compared with nondepressed CHF patients, those with depression were more likely to have comorbid psychiatric disorder, severe medical illness, and severe functional impairment. Depressed patients used more outpatient and inpatients medical services, although this was largely due to the severity of their health problems. Patients often remained depressed for a prolonged period, and over 40% failed to remit during the year following discharge. Factors predicting slower remission included nonhealth-related, stressful life events and low social support; physical health factors at baseline had little effect. The majority of depressed CHF patients did not receive treatment for their depression with either antidepressants or psychotherapy, and did not see mental health specialists any more frequently than did the nondepressed. These findings are of concern and have important implications for the diagnosis and treatment of depression in older patients with heart failure.
    General Hospital Psychiatry 01/1998; 20(1):29-43. · 2.98 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Smoking is a well-established risk factor for cardiovascular disease (CVD). This chapter provides an overview of a program of nursing research relevant to tobacco use in patients with CVD. The Women's Initiative for Nonsmoking (WINS) provides a rich demonstration of a key randomized clinical trial (RCT) on the efficacy of smoking cessation in women. The National Institutes of Health priority for data mining of existing RCTs is demonstrated in the numerous presentations of findings from secondary papers from WINS that answer additional research questions relevant to smoking cessation, including the influence of depression on smoking, myths about and underuse of nicotine replacement therapy. The methodological and logistical challenges inherent in tobacco intervention studies are presented, including a discussion of research needed in the measurement of withdrawal symptoms. Additionally, the role and contributions of nurses serving on the federal guideline development process are highlighted. International research activities of the coauthors from Jordan and Korea are also presented, including a discussion of the need for research in waterpipe use.
    Annual review of nursing research 01/2009; 27:221-42.